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Abstract
Purpose Haskap (Lonicera caerulea L. or blue honeysuckle) is a plant native to the low-lying wet areas and mountains of 
Siberia and northeastern Asia, but is now cultivated in Canada. The dark blue berries are rich in anthocyanins, particularly 
cyanidin-3-O-glucoside. Previously, anthocyanin-rich fruits have been observed to benefit cognitive performance during the 
immediate postprandial period following a single acute dose. However, no study has currently examined the potential for 
haskap berries to influence cognitive performance. Here, we investigate the acute cognitive benefits of an anthocyanin-rich 
haskap berry extract.
Methods A double-blind, counterbalanced, crossover intervention study compared the acute effects of three separate haskap 
berry extract doses, containing 100 mg, 200 mg, and 400 mg anthocyanins, with a sugar-matched placebo. Participants were 
an opportunity sample of 20 older adults, aged 62–81 years. Measures of cognition, mood, and blood pressure were recorded 
at baseline and 1.5 h postprandially.
Results Compared to placebo, the 400 mg dose elicited significantly lower diastolic blood pressure and heart rate. Both 
200 mg and 400 mg doses elicited significantly higher word recall, with the 400 mg dose also significantly improving word 
recognition scores, on an episodic memory task. However, mood, working memory and executive function task results were 
more equivocal.
Conclusions The findings provide evidence for improvements in episodic memory and blood pressure following acute sup-
plementation with haskap berry extract, with higher doses appearing most effective. The cognitive findings concur with 
previous literature that suggests episodic memory effects, and not executive function effects, are most prevalent in older 
adults following anthocyanin-rich berry supplementation. The blood pressure outcome is consistent with a vasodilatory 
mechanism of action.
Keywords Haskap berry · Nutrition intervention · Older adults · Cognition · Blood pressure
Introduction
A rise in the incidence of age-related neurodegenerative 
diseases, and associated health care costs, is predicted to 
result from the ageing demographic of the UK population. 
Much current government thinking is, therefore, focused on 
the promotion of lifelong health, with a view to mitigating 
age-related cognitive changes in healthy older adults. More-
over, recently published National Institute for Health and 
Care Excellence (NICE) guidelines [1] recommends the 
development and support for population-level initiatives to 
reduce the risk of dementia, disability, and frailty by mak-
ing it easier for people to stop smoking, be more physically 
active, reduce their alcohol consumption, maintain a healthy 
weight and, importantly for this research, to adopt a healthy 
diet. However, the efficacy of such dietary interventions on 
the cognitive ageing process is currently under-investigated.
Flavonoids are a class of organic polyphenol micronu-
trients that are found in high concentrations in plant-based 
foods such as berries, tea, cocoa, and whole grains. Flavo-
noids have been linked to improvements in cardiovascular 
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and metabolic health and are also showing particular prom-
ise in terms of their effect on memory and other aspects 
of cognition. In recent years, a large body of evidence has 
emerged from human intervention studies demonstrating 
that the consumption of flavonoid-rich foods is associ-
ated with improvements in cognitive function [2–5]. Spe-
cifically, flavonoids (cocoa flavanols, citrus flavanones and 
berry anthocyanins) have been observed to exert positive 
effects on executive functioning and memory in both older 
adults [6, 7] and children [8–10]. Thus, dietary interventions 
rich in flavonoids may represent a plausible, and publically 
acceptable, route for the amelioration of age-related cogni-
tive decline. Indeed in a recent study of older adults, blue-
berry extract was observed to significantly improve episodic 
memory and visuospatial working memory after 3-month 
supplementation, and to reduce systolic blood pressure after 
both 3- and 6-month supplementation, when compared to a 
control group of participants [11].
Much of the flavonoid-based cognitive research to date 
has focussed on blueberries, citrus fruits, cocoa, and green 
tea; however, other berries including blackcurrants, grapes 
and cherries are increasingly under investigation due to their 
high flavonoid content [2]. Haskap (Lonicera caerulea L. or 
blue honeysuckle) is a plant native to the low-lying wet areas 
and mountains of Siberia and northeastern Asia. The fruit 
from this plant, haskap berries or honeyberries, are elon-
gated berries covered in a dark blue to purple skin. Impor-
tantly, it has recently been ascertained that the haskap berry 
is particularly rich in the flavonoid anthocyanins and may, 
therefore, represent an, as yet, unexplored dietary interven-
tion for neurocognitive health in older adults. The average 
anthocyanin content of haskap berries is 1080 mg per 100 g 
fresh weight of the fruit [12] which compares very favoura-
bly with other fruit sources such as raspberry (50 mg/100 g), 
blackberry (100 mg/100 g), red currant (75 mg/100 g) and 
blueberry (150 mg/100 g) [13]. A number of in vitro and 
in vivo studies have assessed the potential health benefits 
associated with consumption of haskap berries with data 
showing potential application as anti-microbial, anti-can-
cer and anti-inflammatory agents [14]. However, despite 
the high anthocyanin content of the fruit, no studies have 
assessed the impact of haskap supplementation on cogni-
tive performance. This pilot study, therefore, examined the 
effectiveness of a haskap berry intervention for improving 
cognitive performance in older adults. In an acute study we 
compared the effects of several different doses of freeze-
dried haskap berry extract on cognitive performance in older 
adults, with the aim of identifying the optimal dose for acute 
neurocognitive change in this age group.
Materials and methods
Participants
Twenty older adults, aged 62–81 years (mean 70.50, SD 
5.49, 9 male), were recruited from the local area via opportu-
nity sampling. Ethnicity was not formally recorded, but par-
ticipants were predominantly of white British descent. Sam-
ple size was determined by power analysis using GPower 
3.1. Assuming a medium effect size [2], 20 participants were 
needed to detect a significant difference between repeated 
dose conditions with an alpha of 0.05 and 80% statistical 
power. BMI ranged from 16 to 36 kg/m2 (mean 24.94, SD 
4.54). Habitual consumption of fruits and vegetables ranged 
from 3 to 9 daily portions (mean 5.58, SD 1.76). Partici-
pants reported being generally healthy, were non-smokers, 
and were free from diabetes. Regular doses of medications 
commonly used in this age group, such as statins or anti-
hypertensives, were permitted during the trial; however, 
those taking anti-depressant or anti-coagulant medications, 
or irregular doses of other medications were excluded.
Cognitive measures
The selected tasks have all been used in previous crossover 
nutrition intervention studies [2] and included measures of 
working memory (serial 3s and 7s subtraction), attention/
executive function (Attention Network Task, ANT), and 
episodic memory (Auditory Verbal Learning Task, AVLT). 
The tasks were all programmed using E-Prime. To mini-
mise the impact of cognitive practice effects on the study 
outcome [15], the first visit was treated as a familiarisation 
visit where participants received instruction on the tasks 
and became familiar with the study procedure. During this 
visit, participants completed two practice sessions of the 
full task battery but no data were collected. At subsequent 
visits, short practice trials were incorporated at the begin-
ning of each executive function or working memory task, 
for which data were again not collected. Alternate forms of 
stimuli were used for repeat presentations of all tasks, with 
randomisation across visits.
AVLT
This episodic memory task was a multi-trial word list 
learning task with immediate and delayed free recall, and 
delayed recognition components [16]. Participants listened 
to a recording of 15 words and were immediately asked 
to verbally recall as many as possible within a 2-min time 
period. The same word list (List A) was repeated a fur-
ther four times, each followed by a recall period (R1–R5). 
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Another unrelated list of 15 words was then introduced (List 
B). Participants verbally recalled List B (RB) before again 
recalling List A (R6). After a delay of approximately 15 min, 
during which time the remaining cognitive tasks were com-
pleted, participants again verbally recalled List A (R7), then 
performed a visual recognition task selecting List A words 
from a list of 50 words also containing 15 List B foils and 
20 previously unseen words. Different word lists, matched 
for concreteness and familiarity, were used at each test ses-
sion [10]. The dependent variables were the total number of 
correct words recalled/recognised at each repetition, plus 
calculated measures of proactive (R1–RB) and retroactive 
interference (R5–R6), and learning (R5–R1) [16].
Serial subtraction, 3s and 7s
This working memory task used a previously published 
method [17–19], whereby a random number between 800 
and 999 was presented on screen and participants counted 
backwards, entering their answers using the computer num-
ber pad. Participants were required to enter their responses 
as quickly as possible for a total of 2 min. The task was first 
performed subtracting 3s and was then repeated subtracting 
7s. The dependent variables for both 3s and 7s were the 
total number of correct responses and the total number of 
errors recorded in 2 min. The accuracy of each response was 
determined relative to the previous response, whether or not 
the previous response was correct.
ANT
This executive function task combines the Eriksen flanker 
task [20] with the Posner spatial cueing task [21] to inves-
tigate multiple facets of attention: alerting, orienting, and 
executive attention [22]. Participants viewed blocks of 
arrows presented on screen in rapid succession and indicated 
the direction of the arrow closest to a central fixation point 
with a key press (left or right arrow). The target arrow was 
either flanked by arrows pointing in the same (congruent) 
or opposite (incongruent) direction, or was not flanked at 
all. On selected trials, spatial cues were introduced imme-
diately prior to the appearance of the arrows. Task load was 
further manipulated by increasing or decreasing the number 
of flanking arrows across multiple trials [9]. The dependent 
variables were reaction time and accuracy by congruency, 
cue, and load.
Mood measures
The PANAS-Now [23] mood questionnaire, where par-
ticipants rate 20 mood adjectives on a scale of 1–5, and 
a subjective nine-point Likert scale measure of mental 
fatigue [17] were administered at the end of each session of 
cognitive tasks. Dependent variables were mental fatigue 
score, and composite positive affect and negative affect 
scores obtained by summing responses to positive or nega-
tive PANAS items, respectively. PANAS items relating to 
attention (‘alert’ and ‘attentive’) were also analysed indi-
vidually, as anthocyanin-rich berry interventions have previ-
ously shown positive effects on attention [24, 25].
Blood pressure and heart rate
Blood pressure and heart rate measurements were recorded 
using a clinically validated Omron M6 Comfort automatic 
digital upper arm blood pressure monitor. Three repeat 
readings were taken at 2-min intervals and average values 
recorded, in accordance with the manufacturer’s instruc-
tions. To maintain consistency between repeat test sessions, 
blood pressure measurements were recorded in a seated 
position, with the cuff placed on the left arm, and with the 
arm resting on an adjacent desk throughout the measure-
ment. Blood pressure was recorded at the end of the test 
battery when participants had been seated for 25 min.
Other measures
Palatabilty
Palatability of each dose was determined immediately after 
consumption by a nine-item Likert scale questionnaire 
where participants rated various taste dimensions (sweet, 
sour, bitter, pleasant) on a scale of 1–9.
Fruit and vegetable consumption
At the practice visit, participants were given portion size 
definitions for a range of different fruit and vegetable types 
and were asked to estimate their average daily consumption 
of fruits and vegetables.
Body mass index
Weight and height measurements were recorded for each 
participant at the beginning of the practice visit. These were 
used to calculate BMI using the formula: BMI = weight (kg)/
height (m)2.
Haskap berry interventions
The intervention was a commercially available haskap berry 
extract, supplied by Global Direct Commodities Limited, 
Canada. Obtained by alcohol extraction and then freeze-
dried, the extract was standardized to contain 25% antho-
cyanins. Anthocyanin profile and total polyphenol content 
were not quantified. Varying doses of haskap berry extract 
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powder were mixed with low-flavonoid lemon squash (Rocks 
Organic), sugars, and water. Exact quantities are shown in 
Table 1.
Procedure
The double-blind, crossover study design is illustrated in 
Fig. 1. Participants attended the lab on five separate occa-
sions each separated by 1 week with a different dose of 
intervention administered, in counterbalanced order, on each 
occasion. For 24 h prior to each visit, participants followed a 
low-polyphenol diet and were asked to keep a food diary of 
all food and drink consumed. They attended each visit 12 h 
fasted. The usual start time was 9 a.m., though some partici-
pants opted to attend up to 1 h earlier or later. On arrival they 
received a standardized low-polyphenol breakfast of crois-
sants and cream cheese, with water to drink. Fifteen min-
utes was allowed for breakfast. Participants then completed a 
30-min test battery consisting of cognition, mood, and blood 
pressure measures. Testing took place in the following order: 
AVLT (immediate recall), serial 3 s and serial 7 s subtrac-
tion, ANT, AVLT (delayed recall and recognition), mental 
fatigue and PANAS, blood pressure and heart rate.
The intervention was administered in the form of a 250 ml 
beverage, served chilled (5 °C) in an opaque cup, and con-
sumed through a black straw to maintain double-blinding. 
Participants were asked to consume the drink as quickly as 
possible within a maximum 15-min period. After consuming 
the drink, participants completed a palatability questionnaire 
and waited for a total of 90 min before repeating the test bat-
tery. Peak plasma concentrations of anthocyanin metabolites 
accompanied by a peak in vascular response have previously 
been observed between 1 and 2 h postprandially [26]; there-
fore, the test battery was timed to fall within this period. 
During the break, participants were supplied with maga-
zines to read. After testing had been completed, a return 
appointment was made for the following week. At the end 
of the study participants received a £25 payment and a jar 
of haskap berry jam.
Data analysis
All data were analysed using IBM SPSS statistics version 
22. Parametric tests were used throughout after confirming 
that test data met the required assumptions of normality. For 
all RT data, only correct responses were included in mean 
values. Z score analysis was used to identify outliers; data 
points with z score > 3.29 were removed prior to statisti-
cal analysis [27]. A linear mixed model (LMM) using an 
unstructured covariance matrix to model successive repeat 
test sessions was used to analyse data for all measures. 
Baseline performance was included as a repeated covariate, 
and age, BMI, and habitual fruit and vegetable consump-
tion were included as demographic covariates, due to their 
variability amongst this opportunity sample and the known 
impact on physiology and cognitive function. Visit and 
dose were included as fixed factors in the model (visit was 
included to model any residual practice effects [15]). The 
aim of the analysis plan was to determine whether haskap 
berry dose was a significant predictor of cognition/mood 
performance, or blood pressure. Post hoc pairwise compari-
sons were used to investigate any significant effects of dose. 
A Bonferroni correction was applied to all multiple compari-
sons. Significant comparisons are reported (p < 0.05). For 
the ANT task only, the additional factors of congruency, cue 
Table 1  Intervention drink composition
a Extract standardized to contain 25% anthocyanins
Control Low Medium High
Extract (mg) (total 
 anthocyaninsa)
0 (0) 400 (100) 800 (200) 1600 (400)
Fructose (g) 10 10 10 10
Glucose (g) 10 10 10 10
Lemon squash (ml) 30 30 30 30
Water (ml) 220 220 220 220
Fig. 1  Study design
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type, and load, and their respective dose interactions, were 
added to the LMM analysis.
Results
Following publication, data supporting the results reported 
in this paper will be openly available from the University of 
Reading Research Data Archive at http://resea rchda ta.readi 
ng.ac.uk/.
Data were successfully collected for 19 participants. Due 
to an administrative error, data for the post-intervention time 
point following the 200 mg dose were missing for one fur-
ther participant; however, all other data for this participant 
have been included in the analysis.
Visit order effects
Significant visit order effects were observed for men-
tal fatigue [F(3,16.10) = 3.74, p = 0.033], serial 
3s score [F(3,17.95) = 3.32, p = 0.043], serial 3s 
errors [F(3,17.53) = 3.45, p = 0.039], ANT accu-
racy [F(3,392.96) = 11.35, p < 0.001], and ANT RT 
[F(3,368.22) = 14.01, p < 0.001]. In general, cognitive per-
formance was observed to improve over time, with higher 
scores, fewer errors and faster reaction times evident at later 
visits compared with earlier visits. In contrast, ratings of 
mental fatigue worsened over time.
Blood pressure and heart rate
No dose effects were observed for systolic blood pres-
sure [F(3,41.39) = 1.54, p = 0.219]. However, sig-
nificant dose effects were observed for diastolic blood 
pressure [F(3,34.79) = 3.85, p = 0.018] and heart rate 
[F(3,35.03) = 4.48, p = 0.009]. Pairwise comparisons 
revealed that both diastolic blood pressure and heart rate 
were significantly lower following the 400 mg dose when 
compared to the control (p = 0.012 and p = 0.020, respec-
tively). Results are presented in Table 2.
AVLT
There were significant dose effects at recall points R4 
[F(3,30.61) = 5.49, p = 0.004], R5 [F(3,34.99) = 7.34, 
p = 0.001], RB [F(3,32.29) = 6.82, p = 0.001], R6 
[F(3,27.80) = 3.24, p = 0.037], and R7 [F(3,34.71) = 5.49, 
p = 0.003]. Pairwise comparisons revealed that no significant 
differences in recall performance were observed following 
the 100 mg dose, compared to the control. Performance fol-
lowing the 200 mg dose was significantly higher than the 
control at R4 (p = 0.004), R5 (p = 0.002), and R7 (p = 0.002). 
At R5, 200 mg dose performance was also significantly 
higher than the 100 mg and 400 mg doses, (p = 0.002 and 
p = 0.022, respectively). Performance following the 400 mg 
dose was significantly higher than control at R6 (p = 0.028). 
At RB, 400 mg dose performance was also significantly 
lower than the 100 mg and 200 mg doses, (p = 0.034 and 
p < 0.001), respectively. Results are presented in Fig. 2.
There were significant effects of dose for learning 
(R5–R1) [F(3,34.20) = 3.78, p = 0.019] and proactive inter-
ference (PI) (R1–RB) [F(3,16.58) = 6.01, p = 0.006], but not 
for retroactive interference (RI) (R5–R6) [F(3,31.96) = 0.78, 
p = 0.512]. Pairwise comparisons revealed no significant 
differences in proactive interference for any of the doses 
compared to control, although PI was observed to be lower 
following the 200 mg doses compared to the 400 mg dose 
(p = 0.033). Despite the significance of the learning main 
effect, there were no significant pairwise differences in 
learning between any of the doses.
For delayed recognition there was a significant effect 
of dose on the number of words correctly recognised 
[F(3,33.27) = 5.95, p = 0.002]. Pairwise comparisons 
revealed a significantly greater number of words recalled fol-
lowing the 400 mg dose compared to the control (p = 0.013). 
Results for AVLT calculated and recognition variables are 
presented in Table 3.
Serial subtractions
For serial 3s, significant dose effects were evident for num-
ber of correct responses [F(3,32.5) = 5.89, p = 0.002] and 
number of errors [F(3,31.41) = 5.21, p = 0.005]. Pairwise 
comparisons revealed no significant differences in number 
of correct responses compared to the control; however, per-
formance following the 200 mg dose was significantly higher 
than both the 100 mg and 400 mg doses (p = 0.019 and 
p = 0.040, respectively). The number of errors was signifi-
cantly lower following the 200 mg dose compared to the con-
trol (p = 0.002). For serial 7s, significant dose effects were 
evident for number of errors [F(3,6.11) = 27.73, p = 0.001], 
Table 2  Mean (SE) blood pressure and heart rate following varying 
doses of haskap berry extract
Reported values are estimated marginal means with baseline, age, 
BMI, and habitual fruit and vegetable consumption as covariates
Statistical differences from control are indicated, *p < 0.05
Measure Anthocyanin dose (mg)
0 (control) 100 200 400
SBP 
(mmHg)
125.53 
(1.65)
123.35 
(1.64)
122.71 
(1.66)
123.07 (1.64)
DBP 
(mmHg)
75.50 (1.28) 74.32 (1.27) 73.73 (1.29) 72.84 (1.27)*
HR (bpm) 63.02 (1.07) 62.71 (1.06) 61.50 (1.07) 60.63 (1.06)*
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but not for number of correct responses [F(3,31.01) = 0.10, 
p = 0.957]. Pairwise comparisons revealed significantly 
fewer errors (p = 0.014) following the 100 mg dose, com-
pared to the control. However, following the 400 mg dose, 
significantly more errors were made compared to the control 
(p = 0.011). Results are presented in Table 3.
ANT
For ANT accuracy, there was no significant effect of 
dose [F(3,871.61) = 0.99, p = 0.399] and no significant 
dose interaction with congruency [F(3,854.65) = 0.46, 
p = 0.711], cue type [F(9,854.50) = 0.476, p = 0.892], 
or load [F(3,855.22) = 1.15, p = 0.329]. Similarly for 
ANT reaction time, there was no significant effect of 
dose [F(3,777.25) = 1.97, p = 0.117] and no significant 
dose interaction with congruency [F(3,761.25) = 0.34, 
p = 0.794], cue type [F(9,759.52) = 0.73, p = 0.684], or load 
[F(3,759.47) = 1.55, p = 0.200]. Results are presented in 
Table 3.
PANAS and mental fatigue
There were no significant effects of dose on men-
tal fatigue [F(3,34.46) = 0.66, p = 0.585], positive 
affect [F(3,32.95) = 0.53, p = 0.664] or negative affect 
[F(3,37.92) = 1.69, p = 0.185]. However, analysis of individ-
ual PANAS items relating to attention revealed a significant 
effect of dose on ratings of alertness [F(3,36.53) = 10.57, 
p < 0.001], but not attentiveness [F(3,36.97) = 0.90, 
p = 0.448]. Pairwise comparisons revealed significantly 
lower ratings of alertness following the 400  mg dose 
compared with the control (p = 0.028) and 100 mg dose 
(p < 0.001). Alertness following the 200 mg dose was also 
Fig. 2  The effect of dose on 
AVLT word recall across multi-
ple recall points. a Mean recall 
scores for all recall points fol-
lowing varying doses of haskap 
berry extract. b Recall points 
where statistical differences 
between dose conditions were 
observed. Reported values are 
estimated marginal means with 
baseline, age, BMI, and habitual 
fruit and vegetable consump-
tion as covariates. Error bars 
represent standard error of the 
mean. Statistical differences are 
indicated, **p < 0.01, *p < 0.05
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rated lower than the 100 mg dose (p = 0.0010). Results for 
all mood variables are presented in Table 4.
Palatability
There were significant effects of dose on subjective 
ratings of sweetness [F(3,38.85) = 8.86, p < 0.001], 
sourness [F(3,31.48) = 10.18, p < 0.001], bitterness 
[F(3,28.73) = 13.16, p < 0.001], and overall pleasant-
ness [F(3,41.58) = 6.53, p = 0.001]. Pairwise comparisons 
revealed that compared to control, the 200 mg and 400 mg 
doses were rated significantly more sour (p = 0.002 and 
p < 0.001, respectively), and the 400 mg dose was also 
rated more sour than the 100 mg dose (p = 0.035). The 
400 mg was rated significantly more bitter than the control 
(p = 0.001), the 100 mg dose (p < 0.001), and the 200 mg 
dose (p = 0.048). In terms of overall taste, only the 400 mg 
dose was rated significantly less pleasant than the control 
(p = 0.002) and was also rated less pleasant than the 100 mg 
dose (p = 0.035). For sweetness, there were no significant 
differences compared to control; however, the 200 mg and 
400 mg doses were rated significantly less sweet than the 
100 mg dose (p = 0.001 and p = 0.008, respectively).
Discussion
The results demonstrate significant benefits of haskap berry 
extract on both physiological and cognitive outcomes in the 
immediate postprandial period. With respect to the physi-
ological outcomes, the 400 mg dose elicited lower diastolic 
blood pressure and lower heart rate compared to the matched 
control, 1.5 h post-administration. These physiological ben-
efits are likely related to previously observed vasodilatory 
[26] and glucoregulatory [28] effects of anthocyanins. The 
mechanisms for such physiological changes in response to 
flavonoid intervention are known to be dose dependent, and 
the current blood pressure and heart rate outcomes concur, 
Table 3  Mean (SE) cognition 
scores following varying doses 
of haskap berry extract
Reported values are estimated marginal means with baseline, age, BMI, and habitual fruit and vegetable 
consumption as covariates
Statistical differences from control are indicated, **p < 0.01, *p < 0.05
Measure Anthocyanin dose (mg)
0 (control) 100 200 400
AVLT (words)
 Learning 4.13 (0.42) 4.05 (0.43) 5.08 (0.43) 4.84 (0.43)
 PI 0.36 (0.29) − 0.22 (0.29) − 0.37 (0.29) 0.82 (0.29)
 RI 2.92 (0.36) 2.45 (0.36) 2.36 (0.36) 2.39 (0.36)
 Recognition 10.09 (0.43) 10.48 (0.43) 11.45 (0.44) 11.51 (0.43)*
Serial subtraction (in 2 min)
 3s correct 34.18 (1.01) 32.01 (1.01) 35.15 (1.02) 31.89 (0.99)
 3s errors 4.00 (0.40) 3.24 (0.39) 2.28 (0.41)** 3.07 (0.39)
 7s correct 20.27 (0.82) 20.75 (0.84) 20.30 (0.85) 20.63 (0.82)
 7s errors 3.42 (0.32) 2.00 (0.32)* 2.63 (0.31) 4.78 (0.32)*
ANT
 Accuracy (%) 0.97 (< 0.01) 0.97 (< 0.01) 0.97 (< 0.01) 0.98 (< 0.01)
 RT (ms) 573.37 (2.22) 567.13 (2.21) 567.80 (2.27) 569.48 (2.22)
Table 4  Mean (SE) subjective 
mood ratings following varying 
doses of haskap berry extract
Reported values are estimated marginal means with baseline, age, BMI, and habitual fruit and vegetable 
consumption as covariates
Statistical differences from control are indicated, **p < 0.01, *p < 0.05
Measure Anthocyanin dose (mg)
0 (control) 100 200 400
Mental fatigue (/9) 4.74 (0.35) 4.18 (0.35) 4.28 (0.36) 4.36 (0.35)
Positive affect (/50) 29.33 (0.80) 29.68 (0.81) 29.70 (0.81) 28.72 (0.80)
Negative affect (/50) 12.83 (0.50) 11.84 (0.51) 12.63 (0.52) 12.29 (0.51)
Alert (/9) 3.21 (0.17) 3.49 (0.17) 2.95 (0.17) 2.83 (0.17)*
Attentive (/9) 3.63 (0.13) 3.63 (0.13) 3.76 (0.13) 3.54 (0.13)
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with significant effects observed for the highest dose only. 
These blood pressure and heart rate changes are suggestive 
of potential physiological mechanisms of action for observed 
improvements to cognition, through increased blood flow 
to the brain and/or improved uptake of glucose to the brain. 
Previously, a reduction in systolic blood pressure was 
accompanied by improved episodic memory and visuospa-
tial working memory following 3-month supplementation 
with a blueberry extract in healthy older adults [11]. Links 
have also been made between hypertension reduction and 
improvements to cognition [29, 30]. With respect to the cur-
rent cognitive outcomes, the high dose (400 mg) elicited 
improvements to episodic memory, specifically AVLT word 
recall (R6) and recognition. Overall, however, the 200 mg 
dose elicited the majority of episodic memory effects, with 
improvements to immediate and delayed word recall at mul-
tiple recall points (R4, R5 and R7). The 100 mg dose elicited 
no AVLT benefits, suggesting that, as with the physiological 
effects, higher doses may be necessary to influence episodic 
memory.
Working memory effects were more equivocal, with only 
error rates influenced by the berry intervention, not overall 
scores. In the case of serial 3s, the 200 mg dose significantly 
reduced the number of errors compared to control; how-
ever, for serial 7s the 100 mg dose resulted in significantly 
fewer errors, while the 400 mg dose was observed to worsen 
performance. In the previous literature, differing effects for 
serial 3s and 7s have been observed following flavonoid-rich 
cocoa intervention in young adults [17]; the authors posit 
that the two levels of the task may test slightly different 
cognitive domains, with serial 7s drawing more heavily on 
executive function. However the difficulty of this subtraction 
task, particularly for serial 7s, may explain the mixed out-
comes in this sample of older adults. Participants reported 
difficulty with both the working memory and data entry 
aspects of the task, which may have unduly confounded 
task performance irrespective of the berry dose. These work-
ing memory results should, therefore, be interpreted with 
caution. Participants reported no difficulty with the ANT 
executive function task; however, no significant effects were 
observed following any of the haskap berry doses. With 
respect to mood outcomes, there were no significant berry 
effects on positive affect, negative affect, or mental fatigue. 
However, alertness following the 400 mg dose was signifi-
cantly lower than following the control. This observation 
remains unexplained but may be related to taste differences, 
particularly between the 400 mg dose and the control that 
remained evident despite efforts to match the doses for palat-
ability. Specifically, the 400 mg dose was rated most sour, 
most bitter, least sweet, and least pleasant and, therefore, the 
poor taste of this dose may have impacted subjective percep-
tions of mood, or even cognitive performance. Olfactory 
stimuli have previously been observed to influence cognitive 
performance and mood [31]. However, this taste connec-
tion is purely speculative and requires further investigation. 
Taste differences may also have impacted the blinding of 
participants to the intervention; however, participants were 
only informed that the study was investigating the efficacy 
of a range of different haskap berry drinks, with no men-
tion of a control or specific dose conditions. Therefore, the 
data are unlikely to have been unduly influenced by demand 
characteristics.
The findings broadly agree with previous literature. For 
the physiological outcomes, acute blood pressure changes 
have been observed following plum [32] and cherry sup-
plementation [33]. Interestingly, plums, cherries and haskap 
berries all provide a rich source of cyanidin [13]. This spe-
cific anthocyanin compound forms a lower percentage of 
the anthocyanin profile in other berry fruits such as blue-
berries and blackcurrants, for which acute blood pressure 
changes are yet to be observed. Therefore, different fruits 
may provide different physiological benefits depending 
on their anthocyanin profile. Differential glucoregulatory 
effects of individual anthocyanin compounds have previ-
ously been reported [34]. Vasodilatory properties of indi-
vidual compounds are yet to be investigated, but may also 
reveal compound-dependent differences in vascular response 
that would explain why acute blood pressure changes are 
evident following some berry fruits, but not others.
Review of the cognitive literature has revealed that acute 
flavonoid effects in older adults and children are more com-
monly related to memory rather than executive function [2]. 
Similar AVLT results to the current findings were observed 
in primary school children [8] and older adults [35] fol-
lowing acute blueberry supplementation. Acute working 
memory and executive function effects in older adults are 
not apparent in the berry flavonoid literature; however, acute 
working memory and attention benefits have been observed 
in this age group following curcumin supplementation [36]. 
In the current study, there were no executive function ben-
efits observed on the ANT task, while the working memory 
effects proved difficult to interpret. Indeed, it is recom-
mended that an alternative working memory task should 
be considered for inclusion in future older adult studies, as 
many participants found it difficult to navigate the computer 
related requirements of the task. The older adult sample was 
fairly heterogenous with respect to age, BMI, and habitual 
fruit and vegetable consumption, but is, therefore, repre-
sentative of the wider ageing population. This was, however, 
a small sample size and so the cognitive benefits of haskap 
berries should be confirmed in a larger sample. The cur-
rent findings are also limited to the immediate postprandial 
period and so it is recommended to investigate longer term 
supplementation to determine whether the memory benefits 
observed here translate to longer term benefits throughout 
the ageing process.
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Finally, it should be noted that the study used a haskap 
berry extract as a concentrated source of anthocyanins, rather 
than whole berries. The doses here have been quantified as 
anthocyanins, but other polyphenols were also present in 
the extract (not quantified) so the outcome cannot solely be 
attributed to anthocyanins. This is often the case for whole 
food studies or those using extracts of whole foods. Here, the 
intervention was supplemented with fructose and glucose to 
mimic the sugar profile of the natural berries; however, it is 
also recommended to investigate the effects of whole haskap 
berries (in fresh or freeze-dried, powdered form), to confirm 
effect sizes in the presence of additional macronutrients such 
as fibre. The use of whole berries should also mitigate the 
taste issues created by the bitterness of the extract used in the 
current study.
In conclusion, haskap berry extract was observed to sig-
nificantly improve postprandial episodic memory relative 
to a matched control, but showed limited effect on working 
memory or executive function. A significant lowering of dias-
tolic blood pressure and heart rate relative to control was also 
observed, and is suggestive of a vasodilatory or glucoregula-
tory mechanism of action. Higher doses were observed to be 
more effective. Haskap berries may, therefore, be beneficial in 
ameliorating age-related memory deficits through improved 
vascular and metabolic health. As an extension to this work, 
studies investigating both the immediate postprandial and 
longer term cognitive benefits of whole haskap berries are 
recommended.
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